REQUEST A REP

ARISTADA IS COVERED BY A MAJORITY OF HEALTHCARE PLANS

Coverage includes Medicare and Medicaid and most commercial plans1

ARISTADA
COVERAGE IS
AVAILABLE FOR
OF LIVES1*

*Data source: MMIT, September 2017.

This is not a guarantee of payment, coverage, or reimbursement. Alkermes does not provide any advice, recommendation, guarantee, or warranty relating to coverage, reimbursement, or coding for any product or service. Healthcare providers are responsible for determining coverage and reimbursement information and ensuring the accuracy and completeness of claim submissions for their patients. Coding, coverage, and reimbursement vary significantly by payer, patient, and setting of care and are subject to change. Additional information may exist. Actual coverage and reimbursement decisions are made by individual payers.

Find out if ARISTADA is covered by your patient’s insurance plan

View patient coverage

ARISTADA INITIO

Suggested miscellaneous HCPCS codes are:

  • J 3490 – Unclassified drugs OR
  • C 9399 – Unclassified drugs or biologicals
    • Unclassified Drug C codes are used in the Medicare Outpatient Hospital Setting

Unclassified drug codes may be used when no existing national code adequately describes the item of service being billed. Until a specific code is assigned, an unclassified code may be used.

This is not a guarantee of payment, coverage, or reimbursement. Alkermes does not provide any advice, recommendation, guarantee, or warranty relating to coverage, reimbursement, or coding for any product or service. Healthcare providers are responsible for determining coverage and reimbursement information and ensuring the accuracy and completeness of claim submissions for patients. Coding, coverage, and reimbursement vary significantly by payer, patient, and setting of care and are subject to change. Additional information may exist. Actual coverage and reimbursement decisions are made by individual payers.

ARISTADA

ARISTADA® (aripiprazole lauroxil) has been assigned a J-Code: J1942

  • J-Codes are used when submitting a claim for an injectable drug under a patient’s medical benefit
  • Use this J-Code on a medical claim form when ARISTADA has been administered

ARISTADA CARE SUPPORT

ARISTADA Care Support provides a comprehensive suite of services to help make ARISTADA therapy more accessible for your patients

No matter where your patients are in their journey, ARISTADA Care Support is ready to help.

Accessing treatment

ARISTADA Care Support can conduct a full benefit investigation for your patients living with schizophrenia, including prior authorization requirements, in about 15 minutes. We can provide a written summary of benefits usually within 24 hours.

If a prior authorization is needed, ARISTADA Care Support can provide letter of medical necessity templates and authorization forms for ARISTADA INITIO and/or ARISTADA.

If you have a claim denied, ARISTADA Care Support can help obtain information regarding the denial of coverage and provide appeal requirements for ARISTADA INITIO and/or ARISTADA.

Assistance programs available

Providing qualifying uninsured patients who meet program eligibility access to ARISTADA INITIO and ARISTADA treatment at no charge for up to 12 months. Certain restrictions apply.

Helping to reduce qualifying patients’ out-of-pocket costs for ARISTADA to as low as $10 co-pay per prescription. Certain restrictions apply.

ARISTADA INITIO and ARISTADA

If you are located in a hospital setting, your representative can help register your facility for the ARISTADA Hospital Inpatient Free Trial Program. Additional restrictions may apply. Learn more.

Request SamplesProduct Ordering

Clinical educators are available to provide a demonstration of the proper preparation and injection of ARISTADA INITIO™ (aripiprazole lauroxil) and ARISTADA® (aripiprazole lauroxil). Demonstrations can be scheduled by contacting your ARISTADA representative.

Visit aristadacaresupport.com to learn more about coding and billing information

Learn more
Reference: 1. Data on file. Alkermes, Inc.